Nociception Level Index Monitoring During Cesarean Section
NOL-CS
Effect of Nociception Level Index-Guided Intraoperative Analgesia on Postoperative Pain Management During Elective Cesarean Section
1 other identifier
interventional
60
1 country
1
Brief Summary
This prospective randomized controlled trial evaluated the effect of nociception level (NOL) index-guided intraoperative analgesia on postoperative pain management in patients undergoing elective cesarean section under general anesthesia. Sixty patients were randomly assigned to either NOL-guided analgesia or standard intraoperative monitoring. The primary outcome was postoperative pain intensity assessed using the visual analog scale (VAS) during the first 24 hours after surgery. Secondary outcomes included postoperative opioid requirements and time to first breastfeeding. The study aimed to determine whether objective intraoperative nociception monitoring could improve postoperative analgesia and enhance early maternal recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedFirst Submitted
Initial submission to the registry
July 18, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedJuly 22, 2026
July 1, 2026
6 months
July 18, 2026
July 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity assessed using the Visual Analog Scale (VAS)
Postoperative pain intensity was evaluated using a 10-cm Visual Analog Scale (VAS), where 0 indicated no pain and 10 indicated the worst imaginable pain.
10 minutes, 30 minutes, 4 hours, 8 hours, 12 hours, and 24 hours after surgery
Secondary Outcomes (1)
Time to first breastfeeding
Within the first postoperative hour
Other Outcomes (1)
Need for rescue analgesia
Within the first 24 hours after surgery
Study Arms (2)
NOL-Guided Analgesia Group
EXPERIMENTALPatients undergoing elective cesarean section under general anesthesia were monitored intraoperatively using the Nociception Level (NOL) index in addition to standard monitoring. After fetal delivery, fentanyl was administered in 25-mcg boluses when the NOL value remained above 25 for more than 1 minute, with a minimum interval of 5 minutes between doses.
Standard Monitoring Group
ACTIVE COMPARATORPatients undergoing elective cesarean section under general anesthesia received standard intraoperative monitoring. Intraoperative analgesic management was performed according to conventional clinical practice without NOL index guidance.
Interventions
Standard intraoperative monitoring was used for routine anesthetic and analgesic management without NOL index guidance.
The Nociception Level (NOL) index was used to guide intraoperative fentanyl administration after fetal delivery.
Eligibility Criteria
You may qualify if:
- Female patients undergoing elective cesarean section under general anesthesia.
- Ability to provide written informed consent.
You may not qualify if:
- Refusal to participate.
- Emergency cesarean section.
- High-risk pregnancy (including hypertensive disorders of pregnancy, diabetes mellitus, preterm labor, or fetal growth restriction).
- Placental abnormalities.
- History of allergy to any study medication.
- History of malignant hyperthermia.
- Alcohol or substance abuse.
- Severe cardiac disease or severe arrhythmia.
- Peripheral vascular disease.
- Renal or hepatic failure.
- Contraindication to corticosteroid administration.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences Türkiye Haseki Training and Research Hospital
Istanbul, Sultangazi, 34256, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof
Study Record Dates
First Submitted
July 18, 2026
First Posted
July 22, 2026
Study Start
August 15, 2023
Primary Completion
February 15, 2024
Study Completion
February 15, 2024
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share